Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Capsugel To Buy Bend Research

by Ann M. Thayer
September 9, 2013 | A version of this story appeared in Volume 91, Issue 36

Capsugel will acquire Oregon-based Bend Research and make the 38-year-old drug formulation specialist part of its dosage-form solutions unit. Capsugel, a gelatin capsule maker, has been looking to grow since 2011, when Pfizer sold it to the investment firm Kohlberg Kravis Roberts & Co. Between about 1998 and 2008, Bend worked exclusively with Pfizer.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.